MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.clinre.2026.102818

Медицинская библиотека · Clinics and research in hepatology and gastroenterology · 2026

Beyond pharmacotherapy in IBD: feasibility and patient-reported benefits of a six-week multimodal rehabilitation pilot.

Dermine Solène, Bazin Thomas, Alioui Léa, Lecoq Emilie, Jarraya Syrine, Billiauws Lore, Bresteau Clément, El Khatib Myriam, de Castelbajac Flore, Corcos Olivier, Nuzzo Alexandre, Joly Francisca

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Inflammatory bowel disease (IBD) is often associated with fatigue and reduced quality of life, which are not fully addressed by pharmacologic therapy. Evidence for lifestyle interventions remains limited. We evaluated the feasibility and patient-reported effects of a multimodal rehabilitation program to assess its impact on disability, quality of life, and functional outcomes.

METHODS

We conducted a prospective study in adults with IBD referred perioperatively or after a severe flare. The 6-week programme comprised two supervised weekly sessions combining physical activity, education workshops, and individual dietary counselling. Assessments were performed at baseline (W0), end-of-programme (W6), and month 12 (M12). Primary endpoint was the change in IBD-Disk score at W6 (0-100; higher = greater disability). Secondary outcomes included SF-36 quality of life (0-100; higher = better), ECIPE disease-knowledge score (0-39; higher = better), functional capacity tests, biomarkers, and safety.

RESULTS

Thirty-seven patients were included. No serious adverse events occurred. Disability improved significantly at W6 (IBD-Disk -11.9 points; 95%CI -16.9 to -6.9; p = 5 × 10⁻⁵), with 55.6% responders (≥0.5 SD). Quality of life increased (+13.0 points on SF-36; p = 1.1 × 10⁻⁴), and disease knowledge markedly improved (+7.63 ECIPE; p = 1.9 × 10⁻⁹). Physical activity (≥18/45 active patients) increased from 47.2% to 87.5% at W6 (p = 1.39 × 10⁻⁶). Functional outcomes improved statistically significantly. Biomarkers remained stable. Exploratory analyses at 12 months suggested that improvements were partially sustained.

CONCLUSION

A short multimodal rehabilitation program is feasible, safe, and associated with improvements in disability, quality of life, disease knowledge, and physical performance. These findings support the need for larger controlled trials to confirm the effectiveness and long-term sustainability of lifestyle-oriented rehabilitation strategies in IBD care.

Для цитирования: Dermine Solène, Bazin Thomas, Alioui Léa, Lecoq Emilie, Jarraya Syrine, Billiauws Lore, Bresteau Clément, El Khatib Myriam, de Castelbajac Flore, Corcos Olivier, Nuzzo Alexandre, Joly Francisca. Beyond pharmacotherapy in IBD: feasibility and patient-reported benefits of a six-week multimodal rehabilitation pilot.. Clinics and research in hepatology and gastroenterology. 2026. DOI: 10.1016/j.clinre.2026.102818.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.